Edition:
United Kingdom

BrightPath Biotherapeutics Co Ltd (4594.T)

4594.T on Tokyo Stock Exchange

818JPY
6:00am GMT
Change (% chg)

¥47 (+6.10%)
Prev Close
¥771
Open
¥790
Day's High
¥833
Day's Low
¥781
Volume
5,693,500
Avg. Vol
2,081,440
52-wk High
¥968
52-wk Low
¥410

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Kenichi Nagai

45 2011 President, Chief Executive Officer, Representative Director

Teruhiko Sakai

46 2014 Chief Financial Officer, Director of Administration, Director

Yutaka Waki

57 2014 Chief Operating Officer, Director of Research Development, Director

Akira Yamada

58 2004 Director

Hirotaka Takeuchi

71 2015 Independent Director